Lanean...
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. Effective antivirals with safe clinical profile are urgently needed to improve the overall prognosis. In an analysis of...
Gorde:
| Argitaratua izan da: | Acta Pharm Sin B |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169892/ https://ncbi.nlm.nih.gov/pubmed/32318327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.04.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|